Predictions
Infineon Technologies AG
Start price
Target price
Perf. (%)
€27.75
08:01
08:01
-
24.05.23
24.05.23
-0.18%
08:54
08:54
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Apple Inc.
Start price
Target price
Perf. (%)
€131.04
08:00
08:00
-
24.05.23
24.05.23
-0.18%
08:56
08:56
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Hive Blockchain Technologies
Start price
Target price
Perf. (%)
€0.81
23.05.22
23.05.22
€0.50
23.05.23
23.05.23
-2.19%
23.05.22
23.05.22
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bad rating
Risky balance sheet
Endeavour Silver Corp.
Start price
Target price
Perf. (%)
€3.40
23.05.22
23.05.22
€3.00
23.05.23
23.05.23
-0.94%
23.05.22
23.05.22
Fair valuation
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Coinbase Global Inc.
Start price
Target price
Perf. (%)
€62.94
23.05.22
23.05.22
€70.00
23.05.23
23.05.23
-3.86%
08:56
08:56
Standard Investments for future growth
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€155.25
23.05.22
23.05.22
€175.00
23.05.23
23.05.23
-2.03%
08:56
08:56
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Shenandoah Telecommunications Co.
Start price
Target price
Perf. (%)
€20.80
23.05.22
23.05.22
€22.00
23.05.23
23.05.23
0.00%
03.05.22
03.05.22
Wuxi Biologics (cayman) Inc.
Start price
Target price
Perf. (%)
€13.00
23.05.22
23.05.22
€15.00
23.05.23
23.05.23
-
23.05.22
23.05.22
Could be worthwhile Investment >10% per year
Fair valuation
Future proof or reliable business model
Higher risks for its business
Gold Fields Ltd. ADR
Start price
Target price
Perf. (%)
€11.00
23.05.22
23.05.22
-
23.05.23
23.05.23
0.00%
23.05.22
23.05.22
EBIT growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Gold Fields Ltd
Start price
Target price
Perf. (%)
€11.10
23.05.22
23.05.22
-
23.05.23
23.05.23
-2.25%
23.05.22
23.05.22
Very high dividend yield expected
Very positive Cash Flow expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Harmony Gold Mining ADR
Start price
Target price
Perf. (%)
€3.46
23.05.22
23.05.22
-
23.05.23
23.05.23
-0.87%
23.05.22
23.05.22
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
DRDGOLD Ltd. ADR
Start price
Target price
Perf. (%)
€6.40
23.05.22
23.05.22
-
23.05.23
23.05.23
-1.56%
23.05.22
23.05.22
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Bigbear.ai Holdings Inc.
Start price
Target price
Perf. (%)
€9.30
23.05.22
23.05.22
€18.50
23.05.23
23.05.23
0.00%
23.05.22
23.05.22
Could be very worthwhile Investment >20% year
Netflix Inc.
Start price
Target price
Perf. (%)
€178.00
22.05.22
22.05.22
€150.00
22.05.23
22.05.23
-3.70%
08:56
08:56
Could be worthwhile Investment >10% per year
Medium risks for its business
BioXcel Therapeutics Inc
Start price
Target price
Perf. (%)
€12.86
22.05.22
22.05.22
-
22.05.23
22.05.23
-1.63%
23.05.22
23.05.22
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.75
22.05.22
22.05.22
-
22.05.23
22.05.23
-2.78%
23.05.22
23.05.22
Bicycle Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.80
22.05.22
22.05.22
-
22.05.23
22.05.23
-3.57%
08:28
08:28
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.22
22.05.22
22.05.22
-
22.05.23
22.05.23
-1.39%
23.05.22
23.05.22
Dassault Aviation S.A.
Start price
Target price
Perf. (%)
€154.36
20.05.22
20.05.22
€110.00
20.05.23
20.05.23
-2.31%
-
-
Risky Investment
High valuation
Low dividend yield expected
EBIT decline/stagnation expected